Skip to main content

Table 1 Model inputs, varied by mRS score

From: The economic and health burden of stroke among younger adults in Australia from a societal perspective

Probability and utility inputs

State

mRS probability (rangea)

Short term utilityb (rangea)

Long term utility [12,13,14] (rangea)

mRS 0

0.1654 (0.1489–0.1820)b

0.85 (0.76–1.00)

0.85 (0.80–1.00)

mRS 1

0.2964 (0.2668–0.3261)b

0.78 (0.67–0.94)

0.80 (0.75–0.90)

mRS 2

0.2551 (0.2296–0.2806)b

0.67 (0.53–0.89)

0.70 (0.53–0.75)

mRS 3

0.1379 (0.1241–0.1516)b

0.30 (0.12–0.42)

0.51 (0.45–0.65)

mRS 4

0.0276 (0.0248–0.0303)b

0.11 (0.02–0.20)

0.30 (0.25–0.55)

mRS 5

0.0310 (0.0279–0.0341)b

0.03 (0.00–0.07)

0.15 (0.00–0.32)

mRS 6

0.0866 (0.0779–0.0953) [9]

–

–

Short term annual costb, AUD

State

Medical (rangea)

Nonmedical (rangea)

Indirect (rangea)

mRS 0

15,464 (5685-26,522)

570 (0–1140)

14,733 (0–32,196)

mRS 1

21,901 (6106-39,353)

2112 (0–4224)

27,400 (0–50,593)

mRS 2

40,408 (14,837-51,458)

5236 (140–6460)

47,534 (0–87,389)

mRS 3

68,199 (44,273-68,953)

30,821 (13,133-40,867)

36,357 (0–87,389)

mRS 4

85,578 (71,406-103,792)

58,569 (29,341-74,610)

43,301 (0–91,988)

mRS 5

140,089 (71,464-161,818)

82,999 (46,339-70,034)

40,781 (0–87,389)

mRS 6

43,644 (3918-42,359)

19,738 (0–2627)

39,612 (0–82,789)

Long term annual cost, AUD

State

Medical [6, 15] (rangea)

Nonmedical [6, 15] (rangea)

Indirect [16] (rangea)

mRS 0

1400 (0–2800)

576 (0–1152)

–

mRS 1

1400 (0–2800)

576 (0–1152)

2998 (0–5996)

mRS 2

1774 (0–3548)

730 (0–1460)

19,855 (0–39,710)

mRS 3

1774 (0–3548)

730 (0–1460)

27,875 (0–55,750)

mRS 4

13,715 (0–27,430)

5648 (0–11,296)

43,301 (0–86,602)

mRS 5

17,545 (0–35,090)

7225 (0–14,450)

40,781 (0–81,562)

mRS 6

–

–

–

  1. mRS modified Rankin Scale, AUD Australian dollar
  2. aThe range used for sensitivity analyses
  3. bDerived from AVERT trial patient level data